Cargando…
The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis: A multicenter, prospective, non-interventional study in China
Triptorelin is one of the most commonly used gonadotropin-releasing hormone agonists and has been used in the treatment of deep infiltrating endometriosis (DIE). This study aimed to evaluate the efficacy and safety of up to 24 weeks of triptorelin treatment after conservative surgery for DIE. This p...
Autores principales: | Zhu, Libo, Guan, Zheng, Huang, Yan, Hua, Keqin, Ma, Liguo, Zhang, Jian, Yang, Dazhen, Perrot, Valerie, Li, Hongbo, Zhang, Xinmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812645/ https://www.ncbi.nlm.nih.gov/pubmed/35119037 http://dx.doi.org/10.1097/MD.0000000000028766 |
Ejemplares similares
-
Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis: Post-hoc analysis of a multicentre, prospective, real-world study
por: Sun, Wenting, et al.
Publicado: (2021) -
Quality evaluation of endometriosis guidelines using AGREE II
por: Lei, Yan, et al.
Publicado: (2022) -
Correlations between endometriosis, lipid profile, and estrogen levels
por: Zheng, Rong, et al.
Publicado: (2023) -
Bibliometric analysis of global endometriosis research, 2002 to 2021: A review
por: Deng, Siyao, et al.
Publicado: (2023) -
Physical activity and endometriosis risk in women with infertility or pain: Systematic review and meta-analysis
por: Ricci, Elena, et al.
Publicado: (2016)